Update from CredibleMeds for LQT patients

Members with cardiac conditions may like to consider registering with CredibleMeds to be kept up to date with any changes to the QT drugs to avoid list https://crediblemeds.org/everyone/.

We have recently received the following message through CredibleMeds:

September 10, 2020

Addition of six drugs to the QTdrugs categories
We are writing to inform you that the following four drugs have been added to the category of drugs with a Possible Risk of Torsades de Pointes (TdP):

  • Levetiracetam, a drug for the treatment of epilepsy
  • Ozanimod, a drug used to treat multiple sclerosis
  • Remimazolam, a sedative
  • Oliceridine, an opioid used to treat pain

Also, another drug used to treat parasitic infections, Meglumine antimoniate, has been added to the Known Risk of TdP category, and the decongestant, Levmetamphetamine, has been added to the list of Drugs to be Avoided by patients with congenital long QT. 

More to explorer

FAQ’s about myocarditis

myheart cardiologist, Dr Sabiha Gati, will be filming answers to questions our members have about myocarditis to create a FAQ’s about myocarditis.

Share on whatsapp
WhatsApp
Share on facebook
Facebook
Share on twitter
Twitter
Share on reddit
Reddit
Share on email
Email